Hematologic toxicity
. | . | Grades . | . | . | ||
|---|---|---|---|---|---|---|
| Cohort . | Patient no. . | Absolute neutrophil count . | Platelets . | Hemoglobin . | ||
| A | 1 | II (7/4)* | 0 | I | ||
| A | 2 | 0 | 0 | 0 | ||
| A | 3 | 0 | 0 | 0 | ||
| B | 4 | 0 | 0 | 0 | ||
| B | 5 | III (7/16)* | III (5/62)* | 0 | ||
| B | 6 | 0 | 0 | 0 | ||
| B | 7 | NA | NA | NA | ||
| B | 8 | 0 | 0 | 0 | ||
| C | 9 | 0 | 0 | 0 | ||
| C | 10 | 0 | 0 | 0 | ||
| C | 11 | IV (13/54+)* | IV (3/124+)* | IV (13/54+)* | ||
| C | 12 | 0 | 0 | 0 | ||
| D | 13 | 0 | 0 | 0 | ||
| D | 14 | 0 | 0 | 0 | ||
| D | 15 | 0 | 0 | 0 | ||
. | . | Grades . | . | . | ||
|---|---|---|---|---|---|---|
| Cohort . | Patient no. . | Absolute neutrophil count . | Platelets . | Hemoglobin . | ||
| A | 1 | II (7/4)* | 0 | I | ||
| A | 2 | 0 | 0 | 0 | ||
| A | 3 | 0 | 0 | 0 | ||
| B | 4 | 0 | 0 | 0 | ||
| B | 5 | III (7/16)* | III (5/62)* | 0 | ||
| B | 6 | 0 | 0 | 0 | ||
| B | 7 | NA | NA | NA | ||
| B | 8 | 0 | 0 | 0 | ||
| C | 9 | 0 | 0 | 0 | ||
| C | 10 | 0 | 0 | 0 | ||
| C | 11 | IV (13/54+)* | IV (3/124+)* | IV (13/54+)* | ||
| C | 12 | 0 | 0 | 0 | ||
| D | 13 | 0 | 0 | 0 | ||
| D | 14 | 0 | 0 | 0 | ||
| D | 15 | 0 | 0 | 0 | ||
NA indicates not applicable.
Nadir of the cytopenias in weeks/duration of the cytopenias in days.